NEW YORK (GenomeWeb News) – Ayoxxa Biosystems announced today that it has netted €2.6 million ($3.4 million) in a Series A financing round.

The Cologne, Germany-based firm said it will use the proceeds to further develop and scale-up production of in situ encoded bead-based arrays that allow the simultaneous measurement of multiple proteins from small amounts of sample material.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.